In previously published studies, mice with homozygous mutations in factor H exhibited aHUS, a type of thrombotic microangiopathy (TMA) while mouse with heterozygous mutant didn’t show arteriolar lesions (10). Here, CFH is linked to thrombotic microangiopathy.